Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response is a research paper published in Cancer Cell (2020). On theSindex it has a DataRank of 3.0. It has been cited 163 times, with 124 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.765
From this paper's citation signal
Citation Network Contribution
2.3
From 95 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 124 citers.
National Cancer Institute
Grant: CCSG P30 CA060553
National Cancer Institute
Grant: LLS SCOR 7013-17
National Cancer Institute
Grant: LLS TRP 6572-19
National Cancer Institute
Grant: P41 GM108569
National Cancer Institute
Grant: R01 CA198089
National Cancer Institute
Grant: R35 CA220499
National Institutes of Health
Grant: R01AI104739
NCI NIH HHS
Grant: P30 CA060553
Damon Runyon Cancer Research Foundation
Bayer Corporation
Janssen Pharmaceuticals
Uehara Memorial Foundation
Bristol-Myers Squibb
AbbVie
Chemotherapy Foundation
Michael Smith Health Research BC
Pharmaceutical Research and Manufacturers of America Foundation
Terry Fox Research Institute
FWCI
7.83
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords